🔎 Trials Near Me

Beranda › Lupus › Illinois › Chicago

Uji klinis Lupus di Chicago, IL

8 studi untuk Lupus mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Menerima pesertaFase 3
  • Sl0044 50699, Chicago
Usia 16 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06617325

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Menerima pesertaFase 3
  • Research Site, Chicago
  • Research Site, Chicago
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05835310

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

Menerima pesertaFase 2
  • University of Chicago, Chicago
Usia 16 hingga 70 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07328581

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Menerima pesertaFase 1/2
  • Research Site, Chicago
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06897930

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Menerima pesertaFase 1
  • The University of Chicago Medical Center, Chicago
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07085104

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Menerima pesertaFase 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Menerima pesertaFase 1/2
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06121297

Lupus Landmark Study: A Prospective Registry and Biorepository

Menerima pesertaStudi observasional
  • University of Chicago, Chicago
Usia 18 hingga 110 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT05934149

Uji klinis Lupus di kota lain

Studi lain di Chicago

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.